Navigation Links
Chewable Aspirin More Readily Absorbed
Date:5/15/2009

Study suggests higher levels found in bloodstream could improve heart attack treatments

FRIDAY, May 15 (HealthDay News) -- Chewable aspirin is more readily absorbed into the bloodstream, making it the best aspirin choice for people suffering a cardiac incident, University of California, San Diego researchers report.

Volunteers who consumed chewable aspirin had higher levels of aspirin in their blood shortly afterward when compared with people who either swallowed regular aspirin whole or chewed then swallowed regular aspirin, according to the study, scheduled to be presented Friday at the Society for Academic Emergency Medicine's annual meeting in New Orleans.

Doctors sometimes prescribe aspirin to people who have had a cardiac incident or are at high risk for one.

Study abstracts also appear in the suplement to the April issue of Academic Emergency Medicine.

More information

The American Heart Association has more about using aspirin for heart conditions.



-- Kevin McKeever



SOURCE: Society for Academic Emergency Medicine, news release, May 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
3. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
4. Cavities in Children Reduced Over 60 Percent by New Experimental Chewable Mints
5. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
8. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
9. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
10. Aspirin Resistance Boosts Heart Risks in Cardiac Patients
11. Regular, long-term aspirin use reduces risk of colorectal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chewable Aspirin More Readily Absorbed
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... has partnered with Mediaplanet to help educate the many who are unaware of ... section dedicated to aphasia will run within the “Stroke Awareness” campaign. , The ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year ... medicine. Allison Outerbridge is this year’s Life University winner of a ... the university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter ...
(Date:5/26/2016)... , ... May 26, 2016 , ... W.S. Badger ... has been honored with a 2016 When Work Works Award for its use of ... of the national When Work Works project administered by the Families and Work Institute ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to expand ... Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final WNBA ... levels of the game, Connor Sports has committed to a significantly increased focus on ...
(Date:5/26/2016)... , ... May 26, 2016 , ... There are nearly ... than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the ... National Cancer Survivors Day®. , National Cancer Survivors Day® is an annual worldwide ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... and co-development agreement with Therawis Diagnostics GmbH to develop and ... to develop and market PITX2 as a marker to predict ... breast cancer patients. "We are pleased to partner ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama ... $381 billion in 2015.  Though these are challenging ... of opportunity for success for companies that remain ... search of new growth prospects medical device companies ... research and development (R&D) than do companies in ...
Breaking Medicine Technology: